STOCK TITAN

4Front Ventures Corp Stock Price, News & Analysis

FFNTF OTC

Welcome to our dedicated page for 4Front Ventures news (Ticker: FFNTF), a resource for investors and traders seeking the latest updates and insights on 4Front Ventures stock.

News about 4Front Ventures Corp. (FFNTF) centers on its role as a vertically integrated multi-state cannabis operator and on significant legal and financial developments affecting the company. 4Front reports operations in Illinois and Massachusetts and facilities in Washington, with activities spanning cultivation, production, wholesale, and retail through its Mission-branded dispensaries and other outlets.

Recent news has focused on governance changes, financial reporting delays, and formal restructuring processes. The company has issued updates on delayed audited annual financial statements and related disclosures, applications for a management cease trade order, and the subsequent failure-to-file cease trade order issued by the Ontario Securities Commission. These items are important for readers tracking regulatory compliance and trading restrictions on the company’s securities.

Coverage also includes 4Front’s announcements that all of its U.S. subsidiaries filed for voluntary receivership in aid of liquidation under Massachusetts law and that a court-appointed Receiver has been authorized to operate, manage, and pursue the sale of those subsidiaries and their assets. Additional news has described the company’s assignment into bankruptcy under the Canadian Bankruptcy and Insolvency Act and the appointment of a trustee in those proceedings.

Alongside these restructuring developments, earlier releases have highlighted operational updates such as the official ribbon cutting of a large cultivation and production facility in Matteson, Illinois, and commentary on wholesale and retail performance in Illinois, Massachusetts, and Washington. Readers following FFNTF news can use this page to review the sequence of corporate, regulatory, and operational announcements that shape the company’s current situation.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20.68%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.25%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.88%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.77%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.76%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.35%
Tags
management
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.06%
Tags
none
Rhea-AI Summary

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) reported a 6% year-over-year increase in systemwide pro forma revenue, totaling $139.4 million for FY 2022 and $35.6 million for Q4 2022. The company achieved GAAP revenue growth of 13% to $118.5 million for FY 2022. However, Adjusted EBITDA decreased to $27.7 million from $33.9 million in FY 2021. As of December 31, 2022, cash reserves reached $15.2 million, and the company announced positive operational cash flow as of March 2023. 4Front has acquired a third retail license in Illinois, bolstering its strategy in the state.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.41%
Tags

FAQ

What is the current stock price of 4Front Ventures (FFNTF)?

The current stock price of 4Front Ventures (FFNTF) is $0.000001 as of February 4, 2026.

What is the market cap of 4Front Ventures (FFNTF)?

The market cap of 4Front Ventures (FFNTF) is approximately 3.3M.

FFNTF Rankings

FFNTF Stock Data

3.30M
448.45M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Phoenix

FFNTF RSS Feed